January 15, 2019
Until now, myeloma patients whose cancer was resistant to commonly used treatment methods and drugs had nowhere to turn. But a Phase 2 CAR T-cell clinical trial that has just opened at The Princess Margaret could change that. This trial is looking at how effective these CAR T-cells are in patients whose cancer has been...
Continue Reading
Increasing incidence of cancer and rising number of patients showing response failure to alternative treatments is expected to foster growth of the global CAR-T cell therapy market. Rising number of adults and children developing cancer is expected to lead to high demand for an effective and reliable therapeutic treatment approach for improvement of quality of...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand